The pharmacological management of agitated and aggressive behaviour: A systematic review and meta-analysis.


Journal

European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820

Informations de publication

Date de publication:
04 2019
Historique:
received: 07 01 2019
accepted: 10 01 2019
pubmed: 6 2 2019
medline: 29 5 2019
entrez: 6 2 2019
Statut: ppublish

Résumé

Non-pharmacological interventions preferably precede pharmacological interventions in acute agitation. Reviews of pharmacological interventions remain descriptive or compare only one compound with several other compounds. The goal of this study is to compute a systematic review and meta-analysis of the effect on restoring calmness after a pharmacological intervention, so a more precise recommendation is possible. A search in Pubmed and Embase was done to isolate RCT's considering pharmacological interventions in acute agitation. The outcome is reaching calmness within maximum of 2 h, assessed by the psychometric scales of PANSS-EC, CGI or ACES. Also the percentages of adverse effects was assessed. Fifty-three papers were included for a systematic review and meta-analysis. Most frequent studied drug is olanzapine. Changes on PANNS-EC and ACES at 2 h showed the strongest changes for haloperidol plus promethazine, risperidon, olanzapine, droperidol and aripiprazole. However, incomplete data showed that the effect of risperidon is overestimated. Adverse effects are most prominent for haloperidol and haloperidol plus lorazepam. Olanzapine, haloperidol plus promethazine or droperidol are most effective and safe for use as rapid tranquilisation. Midazolam sedates most quickly. But due to increased saturation problems, midazolam is restricted to use within an emergency department of a general hospital.

Identifiants

pubmed: 30721802
pii: S0924-9338(19)30014-8
doi: 10.1016/j.eurpsy.2019.01.014
pii:
doi:

Substances chimiques

Anti-Anxiety Agents 0
Antipsychotic Agents 0
Hypnotics and Sedatives 0
Benzodiazepines 12794-10-4
Promethazine FF28EJQ494
Haloperidol J6292F8L3D
Olanzapine N7U69T4SZR
Lorazepam O26FZP769L
Midazolam R60L0SM5BC

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-100

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Maarten Bak (M)

Department of Psychiatry & Neuropsychology, Maastricht University, the Netherlands; Mondriaan Maastricht, the Netherlands. Electronic address: m.bak@maastrichtuniversity.nl.

Irene Weltens (I)

Department of Psychiatry & Neuropsychology, Maastricht University, the Netherlands; Mondriaan Maastricht, the Netherlands.

Chris Bervoets (C)

Department of Psychiatry, University Psychiatric Centre KULeuven, Louvain, Belgium.

Jürgen De Fruyt (J)

Department of Psychiatry, General Hospital Sint Jan Brugge-Oostende AV, Brugge, Belgium.

Jerzy Samochowiec (J)

Department of Psychiatry Pomeranian Medical University in Szczecin, Poland.

Andrea Fiorillo (A)

Department of Psychiatry, University of Naples SUN, Naples, Italy.

Gaia Sampogna (G)

WHO Collaborating Centre for Research and Training in Mental Health, University of Naples SUN, Naples, Italy.

Przemyslaw Bienkowski (P)

Department of Psychiatry, Medical University of Warsaw, Poland.

W Ulrich Preuss (WU)

Vitos-Klinik Herborn Psychiatry und Psychotherapy, Martin-Luther-University Halle-Wittenberg, Germany.

Blazej Misiak (B)

Department of Genetics, Wroclaw Medical University, Wroclaw, Poland.

Dorota Frydecka (D)

Department of Psychiatry, Wroclaw Medical University, Wroclaw, Poland.

Agnieszka Samochowiec (A)

Institute of Psychology, Dept of Clinical Psychology, Szczecin University, Poland.

Emma Bak (E)

Medical Student, Maastricht University, Maastricht, the Netherlands.

Marjan Drukker (M)

Department of Psychiatry & Neuropsychology, Maastricht University, the Netherlands.

Geert Dom (G)

Antwerp University (UA), Collaborative Psychiatric Research Institute (CAPRI), Edegem, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH